Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy

BACKGROUND: Although pathological complete response (pCR) after multimodal treatment for esophageal cancer is associated to the best prognosis, recurrence may occur in 20–40% of cases. The present study investigated the recurrence pattern and predictive factors of recurrence after pCR in patients wi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Surg Oncol
Main Authors: La Mendola, Roberta, Bencivenga, Maria, Torroni, Lorena, Alberti, Luca, Sacco, Michele, Casella, Francesco, Ridolfi, Cecilia, Simoni, Nicola, Micera, Renato, Pavarana, Michele, Verlato, Giuseppe, Giacopuzzi, Simone
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2020
Assuntos:
Thoracic Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8119402/
https://ncbi.nlm.nih.gov/pubmed/33078313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-09219-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares